Search results

I didn't find an appropriate thread and am not sure whether it warrants its own thread, it possibly does, but in a newspaper article Scheibenbogen has declared that she will be trialling Inebilizumab, which depletes depletes CD19+ B cells, in Long-Covid respectively ME/CFS patients. The article...

Together with Dr. Laubscher they published a paper on Triple Therapy being a cure for LC by treating microclots. They have also spread this narrative on social media, so much that myself and other patients have tried to get access to Triple Therapy or H.E.L.P Apheresis and I know several...

This paper doesn't look impressive to me, in fact it seems ever more concerning as it still seems like they are struggling with decent methodology when Dalton et al had already pointed out clear mistakes. More so there is absolutely no matching between the different groups, neither in sex, age...

That would seem like the better title to me, but perhaps if one looks at whether it reduces severity and duration of LC, which is actually what one wants to do, preventing is also not an ideal title. Accurate would be Paxlovid=Nirmatrelvir+Ritonavir. Sometimes Paxlovid and Nirmatrelvir are used...

I don't think you have to have access to the paper. The majority of it, if not everything, will be the same as in the preprint which was discussed here (it makes sense for someone to check how big the changes between preprint and publication are).

Without having looked at what is happening, I think you are not using the correction notion of highest paid. Highest payout would refer to your end pay out, not the total sum of monetary gains. That is to maximise payout you tend to complete more tasks that have a high pay out since you only end...